IRIS
TRIVELLIN, GIAMPAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.103
NA - Nord America 941
EU - Europa 304
SA - Sud America 282
AF - Africa 30
OC - Oceania 10
Totale 2.670
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 889
SG - Singapore 605
CN - Cina 317
BR - Brasile 241
VN - Vietnam 58
IE - Irlanda 57
FI - Finlandia 56
GB - Regno Unito 35
CA - Canada 32
DE - Germania 31
HK - Hong Kong 26
RU - Federazione Russa 24
AR - Argentina 22
JP - Giappone 21
IT - Italia 20
IN - India 18
CZ - Repubblica Ceca 13
MX - Messico 12
AU - Australia 10
ES - Italia 10
ID - Indonesia 9
SE - Svezia 9
AT - Austria 8
PK - Pakistan 7
BD - Bangladesh 6
DZ - Algeria 6
FR - Francia 6
IQ - Iraq 6
MA - Marocco 6
NL - Olanda 6
PL - Polonia 6
VE - Venezuela 6
ZA - Sudafrica 6
AZ - Azerbaigian 5
CH - Svizzera 5
EC - Ecuador 5
TR - Turchia 5
BE - Belgio 4
CL - Cile 4
DO - Repubblica Dominicana 3
EG - Egitto 3
HU - Ungheria 3
KG - Kirghizistan 3
TN - Tunisia 3
UA - Ucraina 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
IL - Israele 2
JO - Giordania 2
MD - Moldavia 2
NG - Nigeria 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
UY - Uruguay 2
AL - Albania 1
BB - Barbados 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GT - Guatemala 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 2.670
Salva come PNG Salva come JPEG
Città #
Singapore 231
Shanghai 192
The Dalles 158
Dallas 88
Boardman 82
New York 74
Ashburn 67
Beijing 59
Dublin 57
Helsinki 56
Los Angeles 42
São Paulo 24
Hong Kong 23
Phoenix 18
Ho Chi Minh City 17
Santa Clara 17
Gatineau 16
Hanoi 16
Moscow 15
Seattle 15
Brno 12
Houston 11
Boston 10
Brooklyn 10
Rio de Janeiro 10
Melbourne 9
Montreal 9
Chandler 8
Stockholm 8
Council Bluffs 7
Manchester 7
Milan 7
Tokyo 7
Johannesburg 6
Lahore 6
Munich 6
Atlanta 5
Baku 5
Chicago 5
Curitiba 5
Porto Alegre 5
Southwark 5
Vienna 5
Washington 5
Baghdad 4
Belo Horizonte 4
Charlotte 4
Da Nang 4
Denver 4
Guarulhos 4
Higashiosaka 4
Liège 4
Nashville 4
San Francisco 4
St Petersburg 4
São José dos Campos 4
Bishkek 3
Buenos Aires 3
Campinas 3
Caxias do Sul 3
Fortaleza 3
Guayaquil 3
La Marque 3
Leiden 3
London 3
Mexico City 3
Monterrey 3
Naples 3
New Delhi 3
Newark 3
Soissons 3
Sorocaba 3
Tashkent 3
Warsaw 3
Amman 2
Aracaju 2
Assago 2
Belém 2
Benin City 2
Berazategui 2
Bristol 2
Canoas 2
Casablanca 2
Changsha 2
Chennai 2
Chisinau 2
Concord 2
Contagem 2
Dhaka 2
Düsseldorf 2
Florianópolis 2
Geneva 2
Gravataí 2
Haiphong 2
Hangzhou 2
Hortolândia 2
Hải Dương 2
Ipatinga 2
Joinville 2
Juiz de Fora 2
Totale 1.594
Salva come PNG Salva come JPEG
Nome #
Use of G protein-coupled receptor 101 inhibitor, antagonist or inverse agonist for prevention and/or therapeutic treatment of diseases selected from group consisting of acromegaly and gigantism 142
Characterization of GPR101: Transcripts Structure, Expression Pattern, and Signal Transduction Pathways 107
Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms 67
Characterization of GPR101 Expression Across Different Species 60
Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management 60
X-Linked Acro-Gigantism (X-LAG) Due to Microduplications of Chromosome Xq26: A New Disorder and Implications for Acromegaly 54
A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred 51
Characterization of GPR101 transcript structure and expression patterns 50
AIP and its interacting partners 45
An orphan G-protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations 44
CD40LG duplications in patients with X-LAG syndrome commonly undergo random X-chromosome inactivation 43
miR-107 inhibits the expression of aryl hydrocarbon receptor interacting protein (AIP) and is potentially involved in pituitary tumorigenesis 42
Chaperones, somatotroph tumors and the cyclic AMP (cAMP)-dependent protein kinase (PKA) pathway 42
Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus 42
Characterization of the adiponectin promoter + Cre recombinase insertion in the Tg(Adipoq-cre)1Evdr mouse by targeted locus amplification and droplet digital PCR 42
A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers 41
Germline mutations in a G protein identify signaling cross-talk in T cells 41
Filamin A is involved in human intrahepatic cholangiocarcinoma aggressiveness and progression 39
X-linked acro-gigantism (X-LAG): a new form of infant-onset pituitary gigantism 39
Characterization of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutations in Familial Isolated Pituitary Adenoma Families 38
A Novel Mutation in the Upstream Open Reading Frame of the CDKN1B Gene Causes a MEN4 Phenotype 38
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up 38
The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors 37
Xq26.3 Duplication in a Boy With Motor Delay and Low Muscle Tone Refines the X-Linked Acrogigantism Genetic Locus 36
AIP Mutation in Pituitary Adenomas REPLY 36
Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome 36
FAF1 Gene Involvement in Pituitary Corticotroph Tumors 36
cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors 35
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia 35
Genetics of gigantism and acromegaly 34
Increased expression of miR-34a explains the low AIP protein level present in 50% of sporadic somatotropinomas 33
Characterization of SNARE Proteins in Human Pituitary Adenomas: Targeted Secretion Inhibitors as a New Strategy for the Treatment of Acromegaly? 33
Evaluation of CDKN1B germline mutations in a cohort of acromegalic patients with evidences of multiple neoplasia 32
Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism 32
PAM variants in patients with thyrotrophinomas, cyclical Cushing's disease and prolactinomas 31
Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal alpha-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition 31
Increased Population Risk of AIP-Related Acromegaly and Gigantism in Ireland 31
Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion 30
Comparing models and experimental structures of the GPR101 receptor: Artificial intelligence yields highly accurate models 30
Neurofibromatosis Type 1 Has a Wide Spectrum of Growth Hormone Excess 30
Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations 29
Evaluation of mutations in aryl hydrocarbon receptor interacting protein (AIP) in acromegalic sporadic cases and in one FIPA family 29
Evaluation of p27KIP1 germline mutations in familial phaeochromocytoma and clinically suspected MEN1 patients 29
Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease 28
Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants 28
The direct impact of pegvisomant on osteoblast functions and bone development 27
MicroRNAs: Suggested role in pituitary adenoma pathogenesis 27
MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro 27
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 27
SATB1: a gene involved in pituitary development may have a role in somatotroph tumors 27
Oncogene-induced senescence in pituitary adenomas and carcinomas 26
The R304X mutation of the Aryl hydrocarbon receptor Interacting Protein gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? 26
Diagnosis and Treatment of Parasellar Lesions 26
Stable GPR101 over-expressing cell lines as an invaluable tool for functional studies, ligand screening, and the identification of deregulated genes/pathways in patients with X-linked acrogigantism 26
Cyclic 3',5'-adenosine monophosphate (cAMP) signaling in the anterior pituitary gland in health and disease 26
Familial isolated pituitary adenomas: An emerging clinical entity 26
Screening for GPR101 defects in pediatric pituitary corticotropinomas 25
The Glucose-Dependent Insulinotropic Polypeptide Receptor is Overexpressed Amongst GNAS1 Mutation-Negative Somatotropinomas and Drives Growth Hormone (GH)-Promoter Activity in GH3 Cells 25
GHRH excess and blockade in X-LAG syndrome 25
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients 25
GPR101: Modeling a constitutively active receptor linked to X-linked acrogigantism 24
Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation 24
Interaction of AIP with protein kinase A (cAMP-dependent protein kinase) 24
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study 24
Familial pituitary apoplexy as the only presentation of a novel AIP mutation 23
Pituitary gigantism: update on molecular biology and management 23
Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway 23
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers 23
MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics 22
The X-linked acrogigantism-associated gene gpr101 is a regulator of early embryonic development and growth in zebrafish 22
Large genomic aberrations in corticotropinomas are associated with greater aggressiveness 22
GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency 21
Gigantism, Acromegaly, and GPR101 Mutations REPLY 21
Is IGSF1 involved in human pituitary tumor formation? 21
Hereditary endocrine tumours: Current state-of-the-art and research opportunities: GPR101, an orphan GPCR with roles in growth and pituitary tumorigenesis 20
Macronodular Adrenal Hyperplasia due to Mutations in an Armadillo Repeat Containing 5 (ARMC5) Gene: A Clinical and Genetic Investigation 20
Genetics, clinical features and outcomes of non-syndromic pituitary gigantism: experience of a single center from Sao Paulo, Brazil 20
Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice 20
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects 20
IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction 18
Hereditary endocrine tumours: Current state-of-the-art and research opportunities: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA) 18
Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas 17
Totale 2.767
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 0 0 0 0 0 1 4 4 1
2022/202396 4 2 2 2 3 2 0 1 6 4 0 70
2023/2024706 50 31 145 21 36 80 90 50 13 24 61 105
2024/2025952 37 4 18 15 11 139 113 54 94 220 129 118
2025/20261.003 321 143 120 234 131 54 0 0 0 0 0 0
Totale 2.767